首页> 美国卫生研究院文献>World Journal of Gastrointestinal Oncology >MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer
【2h】

MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer

机译:MicroRNA作为大肠癌的诊断和预后生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNAs (miRNAs) are key regulators involved in various tumors. They regulate cell cycle, apoptosis and cancer stemness, metastasis and chemoresistance by controlling their target gene expressions. Here, we mainly discuss the potential uses of miRNAs in colorectal cancer (CRC) diagnosis. We also shed light on the important corresponding miRNA targets and on the major regulators of miRNAs. Furthermore, we discuss miRNA activity in assessing the prognosis and recurrence of CRC as well as in modulating responsiveness to chemotherapy. Based on the various pro-oncogenic/anti-oncogenic roles of miRNAs, the advantages of a therapeutic strategy based on the delivery of miRNA mimics are also mentioned. Together, miRNA seems to be an excellent tool for effectively monitoring and targeting CRC.
机译:MicroRNA(miRNA)是涉及多种肿瘤的关键调节因子。它们通过控制靶基因的表达来调节细胞周期,细胞凋亡和癌干,转移和化学耐药性。在这里,我们主要讨论miRNA在大肠癌(CRC)诊断中的潜在用途。我们还阐明了重要的相应miRNA靶标和miRNA的主要调控因子。此外,我们讨论了miRNA活性在评估CRC的预后和复发以及调节对化疗的反应性方面。基于miRNA的多种促癌作用/抗癌作用,还提到了基于miRNA模拟物传递的治疗策略的优势。在一起,miRNA似乎是有效监控和靶向CRC的优秀工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号